Addleshaw Goddard advises on Aleos Fund I first close
Addleshaw Goddard has advised Aleos Capital on the first close of its Aleos Fund I, which has secured investment commitments exceeding €150 million, surpassing the fund’s initial target size.
The fund aims to invest in companies operating in the life sciences sector, with a particular focus on opportunities related to health and wellbeing, sustainable nutrition, climate and environmental solutions.
Aleos Fund I will target companies with significant growth potential, with investments primarily focused on Spain and Portugal.
Aleos Capital is expected to complete its first investment in a high-growth life sciences company before the fund’s final close, anticipated by the end of the year, with a hard cap of €240 million.
The team
The Addleshaw Goddard team advising Aleos Capital was led by partner and head of funds Isabel Rodríguez, with support from senior associate Enrique Torné and associate Nemesio Fernández.
